WO2003028723A1 - Compositions pharmaceutiques destinee a l'absorption par voie percutanee contenant des derives d'imidazopyridine fondus - Google Patents
Compositions pharmaceutiques destinee a l'absorption par voie percutanee contenant des derives d'imidazopyridine fondus Download PDFInfo
- Publication number
- WO2003028723A1 WO2003028723A1 PCT/JP2002/010031 JP0210031W WO03028723A1 WO 2003028723 A1 WO2003028723 A1 WO 2003028723A1 JP 0210031 W JP0210031 W JP 0210031W WO 03028723 A1 WO03028723 A1 WO 03028723A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acid
- percutaneous absorption
- pharmaceutical compositions
- containing fused
- imidazopyridine derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003532055A JPWO2003028723A1 (ja) | 2001-09-27 | 2002-09-27 | 縮合イミダゾピリジン誘導体を含む経皮吸収用医薬組成物 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001/296798 | 2001-09-27 | ||
JP2001296798 | 2001-09-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003028723A1 true WO2003028723A1 (fr) | 2003-04-10 |
Family
ID=19117973
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2002/010031 WO2003028723A1 (fr) | 2001-09-27 | 2002-09-27 | Compositions pharmaceutiques destinee a l'absorption par voie percutanee contenant des derives d'imidazopyridine fondus |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPWO2003028723A1 (fr) |
WO (1) | WO2003028723A1 (fr) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4788063A (en) * | 1984-08-14 | 1988-11-29 | State Of Israel, Represented By Prime Minister's Office Israel Institute For Biological Research | Drug delivery system |
JPH0482829A (ja) * | 1990-07-20 | 1992-03-16 | Sekisui Chem Co Ltd | 粘着外用剤 |
JPH05946A (ja) * | 1991-06-27 | 1993-01-08 | Nichiban Co Ltd | ケトチフエン含有経皮吸収製剤 |
EP0556008A1 (fr) * | 1992-02-12 | 1993-08-18 | Shionogi & Co., Ltd. | Dérivés d'imidazopyridine condensés à activité psychotropique |
JP2000026282A (ja) * | 1998-07-14 | 2000-01-25 | Shionogi & Co Ltd | 溶出性が改善された硬ゼラチンカプセル剤 |
WO2000053226A1 (fr) * | 1999-03-11 | 2000-09-14 | Saitama Daiichi Pharmaceutical Co., Ltd. | Compositions facilitant l'absorption cutanee |
EP1132094A1 (fr) * | 1998-11-17 | 2001-09-12 | Shionogi & Co., Ltd. | Preparations administrables par voie percutanee d'activateurs des fonctions cerebrales |
-
2002
- 2002-09-27 WO PCT/JP2002/010031 patent/WO2003028723A1/fr active Application Filing
- 2002-09-27 JP JP2003532055A patent/JPWO2003028723A1/ja active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4788063A (en) * | 1984-08-14 | 1988-11-29 | State Of Israel, Represented By Prime Minister's Office Israel Institute For Biological Research | Drug delivery system |
JPH0482829A (ja) * | 1990-07-20 | 1992-03-16 | Sekisui Chem Co Ltd | 粘着外用剤 |
JPH05946A (ja) * | 1991-06-27 | 1993-01-08 | Nichiban Co Ltd | ケトチフエン含有経皮吸収製剤 |
EP0556008A1 (fr) * | 1992-02-12 | 1993-08-18 | Shionogi & Co., Ltd. | Dérivés d'imidazopyridine condensés à activité psychotropique |
JP2000026282A (ja) * | 1998-07-14 | 2000-01-25 | Shionogi & Co Ltd | 溶出性が改善された硬ゼラチンカプセル剤 |
EP1132094A1 (fr) * | 1998-11-17 | 2001-09-12 | Shionogi & Co., Ltd. | Preparations administrables par voie percutanee d'activateurs des fonctions cerebrales |
WO2000053226A1 (fr) * | 1999-03-11 | 2000-09-14 | Saitama Daiichi Pharmaceutical Co., Ltd. | Compositions facilitant l'absorption cutanee |
Also Published As
Publication number | Publication date |
---|---|
JPWO2003028723A1 (ja) | 2005-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL109526A0 (en) | Benzofuranyl- and thiophenyl-alkanecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them | |
ATE132150T1 (de) | 3-alkenyl-1-azabicyclo(3.2.0)hept-2-en-2- carbonsäure-verbindungen | |
DE68916071D1 (de) | 3-Pyrrolidinylthio-1-azabicyclo (3.2.0)hept-2-en-2-carbonsäure-Verbindungen. | |
DE68917023D1 (de) | 3-Pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-en-2-carbonsäureverbindungen. | |
EP1340749A4 (fr) | Derives d'isoxazole | |
DE59401923D1 (de) | Substituierte heterocyclische Carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel | |
BG106439A (en) | Pharmaceutical composition of improved solubility and oral absorptivity, containing benzamide derivative | |
NO940523L (no) | Nye pyrazin-derivater | |
WO2002007677A3 (fr) | Utilisation de derives d'acide valproique et d'amides d'acide 2-valproenique pour le traitement de la manie en cas de desordre bipolaire | |
NZ516100A (en) | Streptogramin derivatives, preparation and compositions containing them | |
KR970010764A (ko) | 크로몬 유도체, 그의 제조방법 및 의약 조성물 | |
AU558261B2 (en) | Dialkylaminoalkyoxybenzylalcohol derivatives | |
WO2003028723A1 (fr) | Compositions pharmaceutiques destinee a l'absorption par voie percutanee contenant des derives d'imidazopyridine fondus | |
EP0345598A3 (fr) | Dérivés d'anthracyclines à activité cytostatique | |
EP0802179A4 (fr) | Derives d'ester d'amidinonaphtyle substitues | |
SE8804696D0 (sv) | Dioxazocine derivatives their preparation and compositions containing them | |
KR960004341A (ko) | 치환1-(7-클로로 퀴놀린-4-일) 피라졸-3- 카르복스아미드 n-옥시드 유도체, 그의 제조 방법 및 그를 함유하는 약학적 조성물 | |
HU901631D0 (en) | Process for the preparation of thienyl-piperazine derivatives and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KR KZ LK LR LS LT LU LV MA MD MG MK MW MX MZ NO NZ OM PH PL PT RO SD SE SG SI SK SL TJ TM TN TR TT UA UG US UZ VC VN YU ZA ZM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) |
Free format text: EXCEPT/SAUF OM, TN, VC, ZM, AP (ZM) |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003532055 Country of ref document: JP |
|
122 | Ep: pct application non-entry in european phase |